OVERVIEW
While molecular testing has long played a key role in guiding treatment decisions for non-small cell lung cancer (NSCLC), this process has grown increasingly complex in recent years. Recent advancements in targeted therapies for NSCLC have driven the need for improved patient assessment to facilitate early and accurate identification of patients with actionable mutations. Indeed, a multidisciplinary approach is needed to select the appropriate diagnostic procedure for tissue sampling and to guide histologic and cytologic assessment. In this symposium, a pathologist, oncologist, and interventionalist will discuss optimal ways for the full team to collaborate together in order to conduct optimized and comprehensive molecular profiling for patients with NSCLC.
GOAL STATEMENT
The goal of this activity is for learners to be better able to collaborate with the multidisciplinary team (MDT) to conduct optimized and comprehensive molecular profiling for patients with NSCLC.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the[LIST][ITEM]Impact of biomarker testing in NSCLC[ITEM]Procedures used to evaluate NSCLC tissue samples[/LIST]Have greater competence related to[LIST][ITEM]Effectively identifying actionable biomarkers in patients with NSCLC[ITEM]Leveraging optimal tissue stewardship practices in the care of patients with NSCLC[/LIST]Demonstrate greater confidence in their ability to[LIST][ITEM]Coordinate with the MDT to optimize care for patients with NSCLC and actionable biomarkers[/LIST]
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.5 [italic][bold]AMA PRA Category 1 Credits[/bold][/italic]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hyatt Regency Chicago
Regency B (West Tower - Ballroom Level)
151 E Wacker Dr
Chicago, Illinois, 60601
United States
This Satellite Symposium is not an official event of CAP23 and is not sponsored, endorsed, or accredited by the CAP or any of the cosponsoring organizations of CAP23.
Supported by an independent educational grant from [bold]Janssen Biotech, Inc. administered by Janssen Scientific Affairs LLC and Novartis Pharmaceuticals Corp[/bold].